Skip to content
Discover sustainable interior design ideas, eco-friendly ho…

Zimbabwe Turns Down ‘One-Sided’ American Healthcare Assistance Agreement Over Information Fears

Medical funding image
The proposed US funding would have supported programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a major American health deal valued at $367m (272 million pounds) spanning five years over the United States' demand for confidential biological samples.

This rejection came to light after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "lopsided".

A government representative later explained that the US was demanding access to biological samples for scientific study and commercial purposes while was not willing to guarantee the benefits from any future medical innovations.

"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has called for more negotiations to find a deal suitable to both sides so the country's critical HIV programme can proceed.

Wider Implications

This development comes after a similar case in Kenya, where a high court suspended a similar deal with the US after concerns were filed about the safety of Kenyans' health data.

After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.

The agency had administered assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance openness and accountability.

According to statements, 16 nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn in new funding.

Details of the Rejected Deal

The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this cooperation might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana argued the arrangement was "unequal".

"Our nation was requested to share its genetic material and health information indefinitely, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that might result from that provided information," he stated.

"Effectively, our country would supply the raw materials for scientific discovery without any certainty that the final treatments would be available to our population if a future pandemic arise."

National Interest and Global Health

He also said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending structures already set up via the international health agency.

The spokesperson cited its Pandemic Benefit-Sharing framework created to manage potential global health emergencies.

"This system is designed to guarantee that when a nation contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to develop them."

The government's concerns over the US deal "should not be misconstrued as opposition to America," he added.

"We welcome continued discussions with our US partners on how subsequent co-operation might be structured in a manner that honours the independence and dignity of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but suggested that talks should continue given that a large portion of the nation's HIV programmes depended on external financing.

"Where specific concerns arise, such as those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group added.

This impasse highlights the continuing tensions between receiving crucial international aid and safeguarding local interests in an increasingly interconnected world.

By

Brent Berry

Sophie is an interior designer and sustainability advocate, passionate about creating beautiful, eco-friendly homes.

Blue Times Living

Type to search articles.